CLINICAL STUDY
Fate of stent-related side branches after coronary intervention in patients with in-stent restenosis
Fernando Alfonso, MD, PhD, FESCa,
Carlos Hernández, MDa,
María José Pérez-Vizcayno, MDa,
Rosana Hernández, MD, PhD, FESCa,
Antonio Fernández-Ortíz, MD, PhD, FESCa,
Javier Escaned, MD, PhD, FESCa,
Camino Bañuelos, MD, FESCa,
Manel Sabaté, MD, PhDa,
Marcelo Sanmartín, MDa,
Cristina Fernández, MDa and
Carlos Macaya, MD, PhD, FESCa
a Interventional Cardiology Unit, Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain
Manuscript received October 8, 1999;
revised manuscript received April 17, 2000,
accepted June 15, 2000.
Reprint requests and correspondence: Dr. Fernando Alfonso, Unidad de Hemodinámica, Servicio de Cardiología Intervencionista, Instituto Cardiovascular, Hospital Universitario "San Carlos," Ciudad Universitaria, Plaza de Cristo Rey, Madrid 28040, Spain
OBJECTIVES
We sought to assess the fate of stent (ST)-related side branches (SB) after coronary intervention in patients with in-ST restenosis.
BACKGROUND
In-ST restenosis constitutes a therapeutic challenge. Although the fate of lesion-related SB after conventional angioplasty or initial coronary stenting is well established, the outcome of ST-related SB in patients with in-ST restenosis undergoing repeat intervention is unknown.
METHODS
One hundred consecutive patients (age 61 ± 11 years, 22 women) undergoing repeat intervention for in-ST restenosis (101 ST) were prospectively studied. Two hundred and twenty-six SB spanned by the ST were identified. The SB size, type, ostium involvement, location within the ST and take-off angle were evaluated. The SB TIMI (Thrombolysis in Myocardial Infarction trial) flow grade was studied in detail before, during, immediately after the procedure, and at late angiography.
RESULTS
Occlusion (TIMI flow grade = 0) was produced in 24 (10%) SB, whereas some degree of flow deterioration ( 1 TIMI flow grade) was observed in 57 SB (25%). The SB occlusion was associated with nonQ wave myocardial infarction in two patients (both had large and diseased SB). Side-branch occlusion at the time of initial stenting (RR [relative risk] 11.1, 95% CI [confidence interval] 3.535.5, p < 0.001), diabetes (RR 3.5, 95% CI 1.110.5, p = 0.02), SB ostium involvement (RR 5.0, 95% CI 1.417.2, p = 0.004), baseline SB TIMI flow grade <3 (RR 5.5, 95% CI 1.718.1, p = 0.005), and restenosis length (RR 1.05 95% CI 1.011.11, p = 0.03) were identified as independent predictors of SB occlusion. Late angiography in 19 initially occluded SB revealed that 17 (89%) were patent again. The long-term clinical event-free survival (81% vs. 82% at two years) in patients with and without initial SB occlusion was similar.
CONCLUSIONS
Occlusion or flow deterioration of SB spanned by the ST is relatively common during repeat intervention for in-ST restenosis. Several factors (mainly anatomic features) are useful predictors of this event. However, most SB occlusions are clinically silent and frequently reappear at follow-up.
|
Abbreviations and Acronyms
| | ACC/AHA | = American College of Cardiology/American Heart Association | | SB | = side branch(es) | | ST | = stent(s) | | TIMI | = Thrombolysis in Myocardial Infarction |
|
This article has been cited by other articles:

|
 |

|
 |
 
P. Massoudy, M. Thielmann, N. Lehmann, A. Marr, G. Kleikamp, A. Maleszka, A. Zittermann, R. Korfer, M. Radu, A. Krian, et al.
Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: A multicenter analysis
J. Thorac. Cardiovasc. Surg.,
April 1, 2009;
137(4):
840 - 845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Taggart
Does prior PCI increase the risk of subsequent CABG?
Eur. Heart J.,
March 1, 2008;
29(5):
573 - 575.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thielmann, R. Leyh, P. Massoudy, M. Neuhauser, I. Aleksic, M. Kamler, U. Herold, J. Piotrowski, and H. Jakob
Prognostic Significance of Multiple Previous Percutaneous Coronary Interventions in Patients Undergoing Elective Coronary Artery Bypass Surgery
Circulation,
July 4, 2006;
114(1_suppl):
I-441 - I-447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Alfonso, R. Melgares, V. Mainar, R. Lezaun, N. Vazquez, J. Tascon, F. Pomar, A. Cequier, J. Angel, M.-J. Perez-Vizcayno, et al.
Therapeutic implications of in-stent Restenosis located at the stent edge.: Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial
Eur. Heart J.,
October 2, 2004;
25(20):
1829 - 1835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Alfonso, J. Zueco, A. Cequier, R. Mantilla, A. Bethencourt, J. R. Lopez-Minguez, J. Angel, J. M. Auge, M. Gomez-Recio, C. Moris, et al.
A randomized comparison ofrepeat stenting with balloon angioplasty in patients with in-stent restenosis
J. Am. Coll. Cardiol.,
September 3, 2003;
42(5):
796 - 805.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|